Dr. Hemant Kumar Bid, Ph.D. accomplished his graduate degree in Medical Biochemistry, recently graduated from Ohio State University with MS (Pharmacology) degree, and has 16 years of experience in the field of cancer drug discovery and health care management. Teaching commercial-scale cultivation operation, medicinal aspects of CBD including the history of cannabidiol, the medicinal potential and the future of cannabinoid medicine, Patient Navigation and the Endocannabinoid System (ECS) including how medical cannabis affects the body, and how it is used to treat illnesses from a neuroscience perspective. He has a passion for Oncology research, pharmacology, Cannabis, and cancer therapy. Extensive experience in biologics, drug discovery, and early development programs, including research activities stretching from drug target validation, assay development, lead optimization, antibody generation utilizing multiple discovery technology platforms and drug screening, in vivo pharmacology, and expertise to create PDx (patient-derived xenograft), preclinical models. Actively engaged in research and the scientific community as an editorial board member for various scientific journals, teaching, and community fundraising for cancer research. Endorsed for leadership and collaborative abilities. Mentored students, trained staff and have given lectures to diverse audiences. Currently, as an Instructor, he teaches Patient Navigation, Commercial Cultivation Operations, The Endocannabinoid System, and CBD Comprehensive at Cleveland School of Cannabis (CSC). As a Consultant at Alcyone Lifesciences, he is involved in preparing and overseeing regulatory submission documents. (Pre IND/IND).
